Medical Marketing and Media

RSS | Login | Register

Totect

April 23, 2008

TopoTarget USA 's sales force of 10 specialty reps has been promoting Totect to oncology nurses and physicians since the product's launch last year.

Rotarix

April 14, 2008

Rotarix is late to a market dominated by another, but the GlaxoSmithKline vaccine for preventing the rotavirus in infants may have a leg up.

Liquadd

April 07, 2008

Liquadd is a new formulation of dextroamphetamine, one of the most frequently prescribed molecules for the treatment of ADHD.

Triesence

April 07, 2008

Triesence is one of the drugs that recently prompted Novartis to plunk down $11 billion for a minority, and possibly larger, stake in eyecare firm Alcon.

Renvela

March 27, 2008

Genzyme finds itself facing a marketing Catch-22 with the launch of Renvela, a new version of the kidney disease drug sevelamer.

Treanda

March 27, 2008

Cephalon has been conducting traditional pre-launch activities for Treanda, the first new therapy approved for the treatment of chronic lymphocytic leukemia (CLL) since 2001.

Ibudone

March 20, 2008

Ibudone's rollout appears to be in line with most branded generic products.

Arcalyst

March 20, 2008

Arcalyst is approved for an orphan disease whose US incidence rate is one-in-a-million patients.

Tekturna HCT

March 13, 2008

The first fixed-dose combination involving Novartis' first-in-class oral renin inhibitor, Tekturna with hydrochlorothiazide (HCT) was approved in the US in January 2008.

Pristiq

March 13, 2008

Wyeth is expected to mount a large sales campaign for Pristiq, a successor drug to Effexor XR, Wyeth's top-selling SNRI whose patent expires in 2010.

« Previous

Most Emailed

Most Recent

RSS